Israel AI Healthcare Diagnostics Infrastructure Development Feasibility Study with HealthTech Market Forecast

Executive Viability Abstract

This feasibility study evaluates the development of a nationwide AI-driven healthcare diagnostic infrastructure in Israel. Leveraging Israel's unique 25-year centralized digital health record system, the project aims to integrate machine learning protocols into standard clinical workflows for radiology, pathology, and cardiology. The study indicates high viability due to existing digital maturity and a strong ecosystem of local HealthTech talent.

## Market Analysis Israel's digital health market is valued at approximately $2.5B, with an expected CAGR of 18.2% through 2028. The ecosystem benefits from four major HMOs (Clalit, Maccabi, Meuhedet, Leumit) that possess longitudinal patient data. Current diagnostic bottlenecks in the public sector—specifically in imaging interpretation—create a massive demand for AI intervention to reduce wait times and error rates. ## Capex Summary Total estimated capital expenditure is $42.5M. This includes: - Tier 4 Data Centers and GPU Clusters (NVIDIA H100 units): $18M - Data Integration Pipelines & Interoperability (FHIR/HL7): $9M - Cybersecurity and Sovereign Cloud Infrastructure: $7.5M - Initial Algorithm Validation and Clinical Trials: $8M ## Revenue Model The infrastructure will utilize a 'Diagnostic-as-a-Service' (DaaS) model. Revenue streams include: 1. B2B SaaS Subscriptions from HMOs and Private Hospitals. 2. Transactional fees per AI-assisted scan/diagnosis ($2-$5 per instance). 3. R&D Partnership fees from global pharmaceutical companies for anonymized, real-world evidence (RWE) insights. ## Financial Projections Year 1-2 will focus on infrastructure build and regulatory clearance (Ministry of Health). Year 3 marks the beginning of nationwide rollout. Operational expenses (Opex) are expected to stabilize at $6M/year following the initial scale-up phase.